|
"劉俊人"的相关文件
显示项目 91-100 / 295 (共30页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2014 |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Chen, Ting-Chih; Tseng, Tai-Chung; Liu, Chen-Hua; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 吳慧琳; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
|
Su, Tung-Hung; Kao, Jia-Horng; Liu, Chun-Jen; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2014 |
Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study
|
Yeh, Yi-Chun; Liu, Chun-Jen; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Shau, Wen-Yi; Chen, Pei-Jer; Lai, Mei-Shu; 賴美淑; 劉俊人; 郭年真; 陳培哲 |
| 國立臺灣大學 |
2014 |
Clinical presentations of patients from different age cohorts with biliary tract stone diseases
|
Hu, Kuang-Chun; Wang, Horng-Yuan; Chang, Wen-Hsiung; Chu, Cheng-Hsin; Lin, Shee-Chan; Liu, Chun-Jen; Wu, Ming-Shiang; Shih, Shou-Chuan; 劉俊人; 吳明賢 |
| 國立臺灣大學 |
2014 |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu, Hui-Lin; Kao, Jia-Horng; Chen, Ting-Chih; Wu, Wen-Hsuan; Liu, Chen-Hua; Su, Tung-Hung; Yang, Hung-Chih; Chen, Ding-Shinn; Chen, Pei-Jer; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin
|
Chen, Ming-Yao; Liu, Chen-Hua; Chen, Ting-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Liu, Chun-Jen; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues
|
Liu, Chun-Jen; 劉俊人 |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立臺灣大學 |
2014 |
A ten-year follow-up of patients with dual chronic hepatitis B and C virus infections: Outcomes and determinants
|
Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals
|
Wong, V. W. -S.; Liu, C. -J.; 劉俊人 |
显示项目 91-100 / 295 (共30页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目
|
